Strata Oncology Companies
Strata Oncology is a precision oncology company that aims to transform cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Their national precision oncology platform serves the needs of patients, providers, and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. They have developed predictive biomarkers for benefit from approved and investigational antibody-drug conjugates, as well as an innovative biomarker algorithm called Immunotherapy Response Score for anti-PD-1/PD-L1 monotherapy benefit. Strata Oncology's key personnel include a co-founder and Chief Medical Officer, Chief Business Development Officer & Chief Compliance and Legal Officer, VP of Compliance & Privacy Officer, and VP of Clinical and Medical Affairs. Their main focus is on the patient, and they strive to push boundaries and think boldly to achieve their goals.
